Cargando…
Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease
Cardiovascular diseases (CVD) remain the major cause of death and premature disability in Western societies. Assessing the risk of CVD is an important aspect in clinical decision-making. Among the growing number of molecules that are studied for their potential utility as CVD biomarkers, a lot of at...
Autores principales: | Bernardi, Stella, Bossi, Fleur, Toffoli, Barbara, Fabris, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856888/ https://www.ncbi.nlm.nih.gov/pubmed/27200369 http://dx.doi.org/10.1155/2016/1752854 |
Ejemplares similares
-
Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System
por: Toffoli, Barbara, et al.
Publicado: (2016) -
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?
por: Bernardi, Stella, et al.
Publicado: (2019) -
TRAIL Modulates the Immune System and Protects against the Development of Diabetes
por: Bossi, Fleur, et al.
Publicado: (2015) -
Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients
por: Bernardi, Stella, et al.
Publicado: (2017) -
TRAIL/DR5 pathway promotes AKT phosphorylation, skeletal muscle differentiation, and glucose uptake
por: Toffoli, Barbara, et al.
Publicado: (2021)